Back
Protagonist Therapeutics Stock Price Chart
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!
Sell
50
PTGX
Protagonist Therapeutics
Last Price:
25.11
Seasonality Move:
25.26%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.67 | Sell |
| 20-day SMA: | 26.89 | Sell |
| 50-day SMA: | 28.3 | Sell |
| 200-day SMA: | 21.81 | Buy |
| 8-day EMA: | 25.77 | Sell |
| 20-day EMA: | 26.65 | Sell |
| 50-day EMA: | 27.06 | Sell |
| 200-day EMA: | 23.51 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 38.14 | Sell |
| Chaikin Money Flow: | 315595 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.92 - 28.42) | Sell |
| Bollinger Bands (100): | (22.84 - 29.14) | Sell |
Protagonist Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 25.15 while PTGX 8-day simple moving average is 25.67, which is a Sell signal.
- The stock price of PTGX is 25.15 while Protagonist Therapeutics 20-day SMA is 26.89, which makes it a Sell.
- Protagonist Therapeutics 50-day simple moving average is 28.30 while PTGX share price is 25.15, making it a Sell technically.
- PTGX stock price is 25.15 and Protagonist Therapeutics 200-day simple moving average is 21.81, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
50
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a Sell
The current Protagonist Therapeutics [PTGX] share price is $25.15. The Score for PTGX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
1.47B
Price in USD:
25.15
Share Volume:
375K
Protagonist Therapeutics 52-Week Range
52-Week High:
33.34
52-Week Low:
13.72
Sell
50
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?
The Protagonist Therapeutics stock price is 25.15 USD today. -
Will PTGX stock go up or go down?
Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protagonist Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 25.15 while PTGX 8-day exponential moving average is 25.77, which is a Sell signal.
- The stock price of PTGX is 25.15 while Protagonist Therapeutics 20-day EMA is 26.65, which makes it a Sell.
- Protagonist Therapeutics 50-day exponential moving average is 27.06 while PTGX share price is 25.15, making it a Sell technically.
- PTGX stock price is 25.15 and Protagonist Therapeutics 200-day simple moving average is 23.51, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
- PTGX Moving Average Covergence Divergence (MACD) indicator is -0.81, suggesting Protagonist Therapeutics is a Sell
- Protagonist Therapeutics Relative Strength Index (RSI) is 38.14, which suggest Protagonist Therapeutics is oversold
- The Bollinger Bands (25) for Protagonist Therapeutics is (25.92 - 28.42), which suggest Protagonist Therapeutics is a Sell
- The Bollinger Bands (100) for Protagonist Therapeutics is (22.84 - 29.14), which suggest Protagonist Therapeutics is a Sell
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.